Characterization of receptors mediating contraction of the rat isolated small mesenteric artery and aorta to arginine vasopressin and oxytocin
- 1 October 1998
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 125 (4), 865-873
- https://doi.org/10.1038/sj.bjp.0702149
Abstract
1. The exact nature of the receptor subtype(s) involved in the action of arg-vasopressin (AVP) on the rat aorta and small mesenteric artery (SMA) is controversial. Therefore, we have studied the effects of the selective V1A receptor antagonists, OPC 21268 and SR 49059, and the oxytocin (OT) receptor antagonist, atosiban, on the AVP- and OT-induced contractions of the two vessels. 2. AVP and OT displayed similar intrinsic activities in the rat aorta and SMA, but AVP was approximately 130 fold and approximately 500 fold more potent than OT, respectively. In the rat aorta, Hill slopes (nH) were similar for OT and AVP. However, in rat SMA, the OT concentration-effect (E/[A]) curve was significantly steeper than the AVP E/[A] curve (nH, = 3.3+/-0.20, 2.3+/-0.15; P<0.001). 3. In the aorta OPC 21268, SR 49059 and atosiban competitively antagonized the AVP and OT E/[A] curves. Except for atosiban and SR 49059 against AVP, competitive antagonism was also observed in the SMA. Atosiban caused concentration-dependent steepening of the AVP E/[A] curve, whereas SR 49059 decreased the upper asymptote. 4. Schild analysis yielded affinities indicative of V1A receptor involvement in both vessels: pKB/ pA2=9.20 9.48, 7.56 7.71 and 6.19 6.48 for SR 49059, OPC 21268 and atosiban, respectively. 5. Neither AVP nor OT relaxed U46619 pre-contracted aorta or SMA in the presence of SR 49059, suggesting no interference of a vasodilatory component. 6. Despite predominant involvement of V1A receptors in both vessels, the different Hill slopes of AVP and OT E/[A] curves as well as the steepening of the AVP E/[A] curves by atosiban are indicative of receptor heterogeneity in the rat SMA.Keywords
This publication has 33 references indexed in Scilit:
- Effect of oxytocin as a partial agonist at vasoconstrictor vasopressin receptors on the human isolated uterine arteryBritish Journal of Pharmacology, 1997
- Information in Agonist Curve Shape for Receptor ClassificationAnnals of the New York Academy of Sciences, 1997
- Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric arteryLife Sciences, 1996
- Vasopressin mediated vasodilation of cerebral arteriesJournal of the Autonomic Nervous System, 1994
- Cloning, Functional Expression and Tissue Distribution of Human cDNA for the Vascular-Type Vasopressin ReceptorBiochemical and Biophysical Research Communications, 1994
- Binding of (3H) SR 49059, a Potent Nonpeptide Vasopressin V1a Antagonist, to Rat and Human Liver MembranesBiochemical and Biophysical Research Communications, 1994
- Characterization of a novel non-peptide vasopressin V1 receptor antagonist (OPC-21268) in the ratJournal of Endocrinology, 1993
- Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissuesLife Sciences, 1992
- Endothelium-independent contractions of human cerebral arteries in response to vasopressin.Stroke, 1990
- Design and uses of selective agonistic and antagonistic analogs of the neuropeptides oxytocin and vasopressinTrends in Neurosciences, 1984